Matinas Biopharma Holdings Inc. (MTNB)
NYSE · Healthcare
Matinas Biopharma Holdings Inc. Net Income 2014–2023
Matinas Biopharma Holdings Inc. annual/quarterly net income history and growth rate from 2014 to 2023. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Matinas Biopharma Holdings Inc. net income for the quarter ending March 31, 2023 was -5.5 M, a 11.23% increase year-over-year.
- Matinas Biopharma Holdings Inc. net income for the twelve months ending March 31, 2023 was -21.9 M, a 33.95% increase year-over-year.
- Matinas Biopharma Holdings Inc. annual net income for 2023 was -22.9 M, a 9.26% increase from 2022.
- Matinas Biopharma Holdings Inc. annual net income for 2022 was -21.0 M, a 9.82% decrease from 2021.
- Matinas Biopharma Holdings Inc. annual net income for 2021 was -23.3 M, a 3.73% increase from 2020.
- Matinas Biopharma Holdings Inc. annual net income for 2020 was -22.4 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Matinas Biopharma Holdings Inc. Net Income — FAQ
Matinas Biopharma Holdings Inc. (MTNB) net income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Matinas Biopharma Holdings Inc.'s net income?
Matinas Biopharma Holdings Inc. (MTNB) reported net income of -$23M for fiscal 2023.
Where can I see MTNB's net income history?
The chart and table above show Matinas Biopharma Holdings Inc.'s net income by year and by quarter, including the growth rate.